JP Morgan Chase’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
DM
VPM
VCM
JP Morgan Chase's INSP Position: Q1 2026 in Review
JP Morgan Chase increased its Inspire Medical Systems (INSP) stake by 18% in Q1 2026, buying an estimated $576K and bringing the position to 53,615 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #3878.
JP Morgan Chase first reported a position in INSP in Q2 2018 and has held it in 32 quarters since. The position peaked at $157M in Q3 2024. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- JP Morgan Chase held 53,615 shares of Inspire Medical Systems worth $2.7M as of Q1 2026.
- JP Morgan Chase bought 8,227 Inspire Medical Systems shares in Q1 2026, an estimated $576K.
- Inspire Medical Systems made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3878 holding.
- JP Morgan Chase first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 32 quarters since.
- JP Morgan Chase's Inspire Medical Systems position peaked at $157M in Q3 2024.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.